Michela Etzi

The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex

M. Pistis, E. Carboni, A. De Simone, 2022, Cells.

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson’s Disease

N. Greig, E. Carboni, M. Casu, 2022, Neurotherapeutics.

Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study

A. Maschio, Giuliana Fusco, A. Pisanu, 2023, Experimental Neurology.